e-learning
resources
ERJ
2008
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cathepsin H and napsin A are active in the alveoli and increased in alveolar proteinosis
Woischnik M., Bauer A., Aboutaam R., Pamir A., Stanzel F., de Blic J., Griese M.
Source:
Eur Respir J 2008; 31: 1197-1204
Journal Issue:
June
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Woischnik M., Bauer A., Aboutaam R., Pamir A., Stanzel F., de Blic J., Griese M.. Cathepsin H and napsin A are active in the alveoli and increased in alveolar proteinosis. Eur Respir J 2008; 31: 1197-1204
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Risk factors associated with the development of interstitial lung abnormalities
Surfactant protein expression at various COPD Gold stages
Dexamethasone inhibits secretory and cytosolic phospholipases A2 in alveolar macrophages in acute lung injury
Related content which might interest you:
Surfactant proteins in pulmonary alveolar proteinosis in adults
Source: Eur Respir J 2004; 24: 426-435
Year: 2004
Differences in the immunolocalization of surfactant protein (SP)-A, SP-D and KL-6 in pulmonary alveolar proteinosis
Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease
Year: 2008
Surfactant dysfunction and alveolar proteinosis
Source: ERS Course 2019 - Summer school of paediatric respiratory medicine 2019
Year: 2019
Surfactant dysfunction and alveolar proteinosis
Source: ERS Skills Course 2017 - Summer school of paediatric respiratory medicine
Year: 2017
Surfactant dysfunction and alveolar proteinosis
Source: ERS Skills Course 2016
Year: 2016
Surfactant dysfunction and alveolar proteinosis
Source: ERS Course 2018 - Summer school of paediatric respiratory medicine
Year: 2018
Pulmonary alveolar proteinosis
Source: Respipedia Article
Year: 2017
Abnormal intraalveolar accumulation of surfactant proteins in adults with pulmonary alveolar proteinosis
Source: Eur Respir J 2002; 20: Suppl. 38, 90s
Year: 2002
Surfactant protein D as a potential serum marker of pulmonary emphysema
Source: Annual Congress 2011 - Smoking-related disorders and smoking prevention
Year: 2011
Human napsin a is a useful serum marker of interstitial lung disease, compared to KL-6, and surfactant protein-D
Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease
Year: 2009
Lysosomal iron in pulmonary alveolar proteinosis: a case report
Source: Eur Respir J 2009; 33: 673-679
Year: 2009
PAS-negative pulmonary alveolar proteinosis
Source: Annual Congress 2008 - Rare clinical cases
Year: 2008
Interstitial lung disease in a baby with a de novo mutation in the SFTPC gene
Source: Eur Respir J 2004; 24: 30-39
Year: 2004
Pulmonary alveolar proteinosis due to a novel mutation in CSF2RA
Source: Annual Congress 2012 - Paediatric bronchology
Year: 2012
Mini-whole lung lavage to treat pulmonary alveolar proteinosis (PAP)
Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key
Year: 2020
Surfactant proteins in interstitial pneumonia
Source: Annual Congress 2005 - Lung-specific serum markers for interstitial lung diseases
Year: 2005
Pulmonary alveolar proteinosis and GM/CSF antibodies
Source: Eur Respir J 2005; 26: Suppl. 49, 30s
Year: 2005
Immunolocalization of surfactant protein-a (SP-A) in the lungs of
pneumocystis
pneumonia
Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia
Year: 2009
Lung cysts in pulmonary alveolar proteinosis.
Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs)
Year: 2018
Determinants of protein concentration in whole lung lavage of patients with pulmonary alveolar proteinosis
Source: Annual Congress 2009 - From genetics to clinics in diffuse parenchymal lung diseases
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept